6 questions answered from cited research · Plain language
Cancer research is producing new treatments for autoimmune diseases by adapting cell therapies like CAR-T cells and targeting shared inflammatory pathways such as IRAK4 and mitochondrial transfer.
Read the full answer →Mitochondrial transfer between cells can reduce inflammation in autoimmune diseases by reprogramming immune cells to stop overactive responses and calm the immune system.
Read the full answer →Hematopoietic stem cell (HSC) therapies can reset the immune system to stop autoimmune attacks, though they carry risks like infection and require careful nutrition and monitoring.
Read the full answer →Siglec signaling pathways are linked to autoimmune and inflammatory disorders, neurodegeneration, and infections in addition to cancer.
Read the full answer →Research shows that targeting shared molecular pathways like Siglec signaling, mitochondrial cell death, and immune metabolism offers new ways to treat both autoimmune disorders and cancer.
Read the full answer →Sialidase biology relates to autoimmune disorders by regulating immune signals through sialic acid, a process that can be targeted to restore balance in the immune system.
Read the full answer →